151 related articles for article (PubMed ID: 2525077)
1. Phase I clinical and pharmacologic trial of trimetrexate in combination with 5-fluorouracil.
Hudes GR; LaCreta F; DeLap RJ; Grillo-Lopez AJ; Catalano R; Comis RL
Cancer Chemother Pharmacol; 1989; 24(2):117-22. PubMed ID: 2525077
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic study of trimetrexate in combination with cisplatin.
Hudes GR; LaCreta F; Walczak J; Tinsley P; Litwin S; Comis RL; O'Dwyer PJ
Cancer Res; 1991 Jun; 51(12):3080-7. PubMed ID: 1828188
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of trimetrexate glucuronate on a five-day bolus schedule: clinical pharmacology and pharmacodynamics.
Grochow LB; Noe DA; Dole GB; Rowinsky EK; Ettinger DS; Graham ML; McGuire WP; Donehower RC
J Natl Cancer Inst; 1989 Jan; 81(2):124-30. PubMed ID: 2909752
[TBL] [Abstract][Full Text] [Related]
4. A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusion.
Bishop JF; Raghavan D; Olver IN; Reece P; Morris R; Friedlander ML
Cancer Chemother Pharmacol; 1989; 24(4):246-50. PubMed ID: 2526692
[TBL] [Abstract][Full Text] [Related]
5. A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics.
Grochow LB; Noe DA; Ettinger DS; Donehower RC
Cancer Chemother Pharmacol; 1989; 24(5):314-20. PubMed ID: 2758561
[TBL] [Abstract][Full Text] [Related]
6. A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injections.
Jolivet J; Landry L; Pinard MF; McCormack JJ; Tong WP; Eisenhauer E
Cancer Chemother Pharmacol; 1987; 20(2):169-72. PubMed ID: 2959389
[TBL] [Abstract][Full Text] [Related]
7. Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma.
Conti JA; Kemeny N; Seiter K; Goker E; Tong W; André M; Ragusa K; Bertino JR
J Clin Oncol; 1994 Apr; 12(4):695-700. PubMed ID: 7512128
[TBL] [Abstract][Full Text] [Related]
8. A phase I and pharmacokinetic study of trimetrexate using a 24-hour continuous-injection schedule.
Allegra CJ; Jenkins J; Weiss RB; Balis F; Drake JC; Brooks J; Thomas R; Curt GA
Invest New Drugs; 1990 May; 8(2):159-66. PubMed ID: 2143500
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancer.
Reece PA; Morris RG; Bishop JF; Olver IN; Raghavan D
Cancer Res; 1987 Jun; 47(11):2996-9. PubMed ID: 2952262
[TBL] [Abstract][Full Text] [Related]
10. Phase I studies of trimetrexate using single and weekly dose schedules.
Huan SD; Legha SS; Raber MN; Krakoff IH
Invest New Drugs; 1991 May; 9(2):199-206. PubMed ID: 1831442
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil and methotrexate administered simultaneously as a continuous infusion. A phase I study.
Lokich JJ; Phillips D; Green R; Paul S; Sonneborn H; Zipoli TE; Curt G
Cancer; 1985 Nov; 56(10):2395-8. PubMed ID: 4042072
[TBL] [Abstract][Full Text] [Related]
12. A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer.
Blanke CD; Shultz J; Cox J; Modiano M; Isaacs R; Kasimis B; Schilsky R; Fleagle J; Moore M; Kemeny N; Carlin D; Hammershaimb L; Haller D
Ann Oncol; 2002 Jan; 13(1):87-91. PubMed ID: 11863117
[TBL] [Abstract][Full Text] [Related]
13. Phase I clinical and pharmacokinetic study of trimetrexate using a daily x5 schedule.
Stewart JA; McCormack JJ; Tong W; Low JB; Roberts JD; Blow A; Whitfield LR; Haugh LD; Grove WR; Lopez AJ
Cancer Res; 1988 Sep; 48(17):5029-35. PubMed ID: 2970294
[TBL] [Abstract][Full Text] [Related]
14. Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study.
Punt CJ; Keizer HJ; Douma J; Skovsgaard T; Schüller J; Muller EW; Ten Napel CH; Croles JJ; Lochs H; Zhang J; Hammershaimb L
Ann Oncol; 2002 Jan; 13(1):81-6. PubMed ID: 11865814
[TBL] [Abstract][Full Text] [Related]
15. Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors.
Bhalla KN; Kumar GN; Walle UK; Ibrado AM; Javed T; Stuart RK; Reed C; Arbuck SG; Walle T
Clin Cancer Res; 1999 Jul; 5(7):1723-30. PubMed ID: 10430075
[TBL] [Abstract][Full Text] [Related]
16. Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer.
Schilsky RL; Hohneker J; Ratain MJ; Janisch L; Smetzer L; Lucas VS; Khor SP; Diasio R; Von Hoff DD; Burris HA
J Clin Oncol; 1998 Apr; 16(4):1450-7. PubMed ID: 9552051
[TBL] [Abstract][Full Text] [Related]
17. Leucovorin enhances cytotoxicity of trimetrexate/fluorouracil, but not methotrexate/fluorouracil, in CCRF-CEM cells.
Romanini A; Li WW; Colofiore JR; Bertino JR
J Natl Cancer Inst; 1992 Jul; 84(13):1033-8. PubMed ID: 1376779
[TBL] [Abstract][Full Text] [Related]
18. Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.
Mani S; Rudin CM; Kunkel K; Holmlund JT; Geary RS; Kindler HL; Dorr FA; Ratain MJ
Clin Cancer Res; 2002 Apr; 8(4):1042-8. PubMed ID: 11948111
[TBL] [Abstract][Full Text] [Related]
19. Phase I studies with trimetrexate: clinical pharmacology, analytical methodology, and pharmacokinetics.
Lin JT; Cashmore AR; Baker M; Dreyer RN; Ernstoff M; Marsh JC; Bertino JR; Whitfield LR; Delap R; Grillo-Lopez A
Cancer Res; 1987 Jan; 47(2):609-16. PubMed ID: 2947679
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
